Literature DB >> 3801029

Tumor necrosis factor-induced alterations in circulating leukocyte populations.

D G Remick, J Larrick, S L Kunkel.   

Abstract

Tumor necrosis factor is a potent agent possessing diverse biological functions. We investigated the effects of intravenous administration of human recombinant tumor necrosis factor (TNF) on immune cell populations in CBA/J mice. The animals developed a significant lymphopenia and neutrophilia both reaching a maximum at 4 hours post-injection with a trend towards resolution to normal values by 6 hours. The lymphopenia was both relative and absolute. Similarly, the neutrophilia was both relative and absolute and was due to the presence of both immature and mature neutrophils. As the neutrophilia and lymphopenia occurred concomitantly, there was no difference at any time point in the total number of peripheral blood white cells. Extensive controls were done to rule out LPS contamination in the TNF preparation. These data demonstrate the potent effects of intravenous administration of human recombinant tumor necrosis factor on peripheral blood constituents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801029     DOI: 10.1016/s0006-291x(86)80246-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.

Authors:  P J Baker; C E Taylor; P W Stashak; M B Fauntleroy; K Hasløv; N Qureshi; K Takayama
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.

Authors:  K Takayama; N Qureshi; B Beutler; T N Kirkland
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide.

Authors:  M Petersen; R Steadman; M B Hallett; N Matthews; J D Williams
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

4.  Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.

Authors:  D G Remick; R M Strieter; M K Eskandari; D T Nguyen; M A Genord; C L Raiford; S L Kunkel
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

5.  Human rTNF alpha augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1 alpha.

Authors:  J T Roll; K M Young; R S Kurtz; C J Czuprynski
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

6.  Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.

Authors:  T Yoneda; M A Alsina; J B Chavez; L Bonewald; R Nishimura; G R Mundy
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.